Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications

E-ISSN： 1873-4286|13|9|933-962

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.9, 2007-03, pp. : 933-962

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New inhibitors of poly(ADP-ribose) polymerase and their potential therapeutic targets

By Cosi Cristina

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 7, 2002-07 ,pp. : 1047-1071

Informa Healthcare

Access to resources Recommend Favorite

New inhibitors of poly(ADP-ribose) polymerase (PARP)

By Peukert Stefan Schwahn Uwe

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. : 1531-1551

Informa Healthcare

Access to resources Recommend Favorite

Poly(ADP-Ribose) Polymerase Inhibitors

Current Medicinal Chemistry, Vol. 10, Iss. 4, 2003-01 ,pp. : 321-340

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP)-Ribose Polymerase-1 Inhibitors as a Potential Treatment for Cocaine Addiction

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-08 ,pp. : 727-730

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP-ribose) polymerase inhibitors in the prevention of neuronal cell death

By Larner Andrew J

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 481-487

Informa Healthcare

Access to resources Recommend Favorite